It’s an immune system booster which assists in preventing serious and life-threatening diseases. Vaccines “teach” the body how to defend itself against microorganisms, such as viruses or bacteria. As a result, vaccinated people do not get sick or have a mild infection. It is a natural way to deal with infectious diseases, and our goal is to test this discovered vaccine to make sure all of the population is safe and healthy against COVID-19. Vaccines prevent 2 to 3 million deaths each year and are rigorously tested throughout the different phases of clinical trials.
This study counts on people like yourselves to provide their valuable time for our experienced team to analyse and affirm the efficiency of the vaccine.
The volunteer might experience certain side effects that are usually mild and are resolved on their own. Some of the common side effects can include soreness, swelling and/or redness at the site where the vaccine is injected. Other mild symptoms might include muscle aches, slight fever, nausea, diarrhoea, lethargy, fatigue, and headaches.
The common side effects usually diminish on their own, and should not be of any concern; however if symptoms persist for more than 24 hours, please call the principal investigator on 037072777
Our research team will collect personal information as a part of trial. This information is held by the research team and will be kept confidential. No third parties will have access to your personal information at any time during, or after the trial.
Once the subject signs the consent form, he/she can be on the study for up to 201 days (7 days screening, + 180 days treatment / observational periods + 14 days visit window = 201 days)
We respect your choice as a volunteer; this means that you can decide to pull out of the trial at any point in time, with absolutely no repercussions.
All volunteers participating in the trial will be rewarded for their time and effort.
Volunteers compensation could reach AED1500
To ensure the safety and effectiveness of the vaccine, it has been tested during a large number of stages and in numerous pre-clinical trials. On 3rd August 2020, phases 1 and 2 clinical trials of the vaccine have been completed with the highest standards of safety and quality.
The vaccine has induced a strong antibody and cellular immune response and all participating volunteers of the previous stages trial are feeling well. There was no observation of unpredicted or unwanted side effects and not a single participant in the phases 1 and 2 clinical trials has gotten infected with COVID-19 after being administered with the vaccine. In Russia, clinical trials of Sputnik V have been ongoing since September 2020. Over 20,000 people have been enrolled so far out of 40,000 planned.
The high immune response was confirmed by high precision tests for antibodies in the blood serum of volunteers (including analysis for antibodies that neutralize the coronavirus), as well as the ability of the immune cells of the volunteers to activate in response to the spike S protein of the coronavirus, which indicates the formation of both antibody and cellular immune vaccine response.
Full information regarding the stages of the vaccine, and how it has already been tested will be provided to you to make a fully informed decision about participating in the trial.
Not a single participant in the current clinical trials has gotten infected with COVID-19 after being administered with the vaccine.